Jillian C. Evanko Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 day, 6 hours ago
Jillian C. Evanko has an estimated net worth of at least $18.3 million*, as of yesterday. They own 137,666 shares of GTLS stock. They have sold 0 shares of GTLS stock since 2021, for an estimated $-475,590.
Jillian C. Evanko $GTLS SEC Form 4 Insider Trading
Jillian C. Evanko has filed a total of 5 insider trades in $GTLS since 2021. Their most recent trade was a purchase of 350 shares, made on Mar 06, 2025. Their largest trade was a purchase of 2,375 shares, made on Mar 20, 2023. We estimate that they now own 137,666 shares of $GTLS, worth an estimated $18.8 million.
Insider Trading at $GTLS
There have been a total of 25 insider trades reported at $GTLS since 2021, with 20,057 shares purchased and 2,250 shares sold. The most active insider traders in $GTLS stock have been Jillian C. Evanko, Gerald F Vinci, and Herbert Hotchkiss. The most recent trade was a purchase of 328 shares reported by Joseph Robert Brinkman (VP & Chief Financial Officer), made on Mar 14, 2025.
History of Insider Stock Trades by Jillian C. Evanko
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
GTLS
|
Purchase | 350 | Mar 06, 2025 | March 6, 2025, 9:40 p.m. |
|
GTLS
|
Purchase | 303 | Nov 15, 2024 | Nov. 15, 2024, 5:35 p.m. |
|
GTLS
|
Purchase | 440 | Sep 05, 2024 | Sept. 5, 2024, 10:11 a.m. |
|
GTLS
|
Purchase | 490 | May 10, 2024 | May 10, 2024, 4:02 p.m. |
|
GTLS
|
Purchase | 2,375 | Mar 20, 2023 | March 20, 2023, 9:47 a.m. |
$GTLS Executives and Stock Owners with Insider Trades
-
Jillian C. Evanko, President and CEO
-
Gerald F Vinci, VP & Chief Human Resources Ofc
-
Herbert Hotchkiss, VP, GC and Secretary
-
Douglas A Jr. Ducote, Chief Technology Officer
-
Joseph Robert Brinkman, VP & Chief Financial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.